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ABBREVIATIONS 
Arg  -  L-arginine  
BiP  -  heavy chain immunoglobulin binding protein 
b.w.  -  body weight 
BRX-220  -  (+)-/R/-N-[2-hydroxy-3-(l -piperidinyl)-propoxy]-pyridine-l -oxide-3-
carboximidoil-chloride  (Z)-maleate (1:1) 
BU  -  Bergmeyer units 
CCK  -  cholecystokinin-octapeptide  
CWI  -  cold-water immersion 
GPx  -  glutathione peroxidase 
GRP  -  glucose-regulated protein 
GSH  -  reduced glutathione  
HPLC  -  high performance liquid  chromatography 
HSP(s)  -  heat shock protein(s) 
HWI  -  hot-water immersion 
IL  -  interleukin  
i.p.  -  intraperitoneal^  
i.v.  -  intravenously  
MDA  -  malonyl  dialdehyde  
NF-KB  -  nuclear factor kappa B 
PMSF  -  phenylmethyl  sulphonyl fluoride 
PB  -  pentobarbital  
pw/bw  -  pancreatic weight/body weight ratio 
s.c.  -  subcutaneously  
SA  -  sodium arsenite 
SOD  -  superoxide dismutase 
TAP  -  trypsinogen activation peptide 
TBA  -  thiobarbituric  acid  
TC  -  sodium taurocholate 
TNF-a  -  tumor necrosis factor-a 
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SUMMARY 
Background.  Heat  shock  proteins  (HSPs)  are  a  group  of  highly  conserved,  ubiquitous  and  
functionally  related  proteins  that  play  an  essential  part  in  cell  survival.  Following  stress  
conditions,  many  cellular  proteins  become  partially  or  completely  denatured  or  malfolded.  
HSPs  recognize  this,  bind  to  the  damaged  proteins,  and  stabilize  and  refold  them,  thereby  
preventing  or  dissolving  otherwise  irreversible  aggregation.  HSPs  are  also  involved  in  the  
transport  and  translocation  of  different  proteins  and  the  biogenesis  and  degradation  of  
proteins,  regulating  their  structures  and  functions  under  normal  physiological  conditions.  
HSPs  are  divided  into  six  families,  according  to  their  molecular  mass  (e.g.  HSP60  and  
HSP72).  Cells  subjected  to  a mild,  sublethal  stress  event  sufficient to  increase  the  levels  of  
HSPs  are able to  survive  a subsequent  more serious  stress event.  HSP preinduction is  known  
to protect  the pancreas  against  cerulein-  and dibutylin  dichloride-induced  pancreatitis  in  rats  
or against choline-deficient ethionine-supplemented  diet model pancreatitis in mice. 
The  aims  of  the  present  investigations  summarized  in  this  thesis  were  to  investigate  the  
potential effects of  cytoprotective  HSP pre-/co-induction  by thermal  (Annex No.  I-III)  [cold-
(CWI) and hot-water immersion (HWI)] and non-thermal  (Annex No.  IV-V)  [sodium arsenite  
(SA), BRX-220] methods on three acute pancreatitis models in rats. 
Methods. Male  Wistar rats were subjected to CWI, HWI and SA treatments and injected with 
cholecystokinin-octapeptide  (CCK),  sodium  taurocholate  (TC),  or  L-arginine  (Arg)  at  the  
peak level of pancreatic  HSP synthesis,  as determined by  Western blot analysis.  In a  separate  
set of experiments,  rats were  administered the non-toxic  HSP co-inducer pro-drug,  BRX-220,  
orally  followed  by  subcutaneous  CCK  injections.  This  whole  procedure  was  repeated  for  5  
days. The rats were  exsanguinated  through the abdominal  aorta. The pancreas and lungs were 
quickly removed,  cleaned of  fat and lymph nodes,  and frozen  at -70  °C until  processing.  We  
determined  the  serum  amylase  activity  and  cytokine  concentrations,  the  plasma  trypsinogen  
activation peptide  concentration,  the pancreatic  weight/body  weight  ratio,  the DNA  and total 
protein contents of the  pancreas,  the levels  of pancreatic  HSP60  and HSP72,  the  activities  of  
pancreatic  amylase,  lipase,  trypsinogen  and  free  radical  scavenger  enzymes  (superoxide  
dismutase,  catalase  and  glutathione  peroxidase),  the  degree  of  lipid  peroxidation,  protein  
oxidation  and  the  reduced  glutathione  level.  Lung  myeloperoxidase  activity,  as  a  marker  of  
tissue  leukocyte  infiltration,  was  measured.  Histopathological  investigation  of  the  pancreas  
was also performed in all  cases.  
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Results and conclusions.  We have shown that HWI and SA specifically induces the synthesis 
of  pancreatic  HSP72,  while  CWI  specifically  elevates  the  level  of  pancreatic  HSP60.  We  
demonstrated  the  differential  protective  effects  of  water  immersion  pretreatment  on  three  
acute  pancreatitis  models.  Water  immersion  pretreatment  (and  possibly  HSP60  and  HSP72)  
exerts  a  definite  protective  effect  in  mild  pancreatitis,  whereas  this  was  not  seen  in  more  
severe  acute  pancreatitis  models.  On  the  other  hand,  the  protective  effect  of  hyperthermia  
seems to be independent of  the increased HSP72 synthesis since the non-thermal induction of 
HSP72  by  SA  failed  to  reduce  the  severity  of  CCK-induced  acute  pancreatitis  and  
pancreatitis-associated  lung  injury.  We  have  found that  repeated  injections  of  supramaximal  
doses of  CCK for 5 days paradoxically  decrease  the levels  of  pancreatic  HSP60  and HSP72.  
This reduction was ameliorated by the administration of the non-toxic  HSP co-inducer,  BRX-
220. We were the  first to  demonstrate  that  a non-toxic  HSP-inducer  compound  administered  
during  the  course  of  the  disease  can  protect  against  CCK-induced  pancreatitis.  These  
cytoprotective effects of the drug are most probably due to the upregulated synthesis of HSPs. 
Our  findings  suggest  the  possible  roles  of  HSP60  and  HSP72,  in  the  protection  against  
interstitial  acute  pancreatitis  and the  potential  therapeutic  applications of  HSP-inducer  drugs  
in the treatment of acute pancreatitis.  Further studies  are needed to investigate  the promising 
use of these compounds in humans. 
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1. INTRODUCTION 
Acute pancreatitis  is  still  a disease  with an unacceptably  high morbidity  and mortality 
(5-10 %,1).  The severity of  acute pancreatitis ranges from edema to necrosis of  the  gland (1). 
The  edematous  form of  the  disease  occurs  in  about  80-85% of  patients  and  is  self-limited,  
with  recovery  in  a few  days  (1,2).  In the  15-20% of  patients  with  the  most  severe  form of 
pancreatitis,  hospitalization  is  prolonged  and  commonly  associated  with  infection  and other  
complications  including multiple organ failure (1,2).  Treatment of the disease remains a great 
challenge.  The aims of the present investigations  summarized in this thesis were to  investigate  
the potential  effects of  cytoprotective  heat  shock  protein  (HSP) pre-/co-induction  by thermal  
(Annex  No.  I-III)  [cold-water  (CWI)  and  hot-water  immersion  (HWI)]  and  non-thermal  
(Annex No.  IV-V)  [sodium arsenite (SA),  BRX-220]  methods,  on different acute  pancreatitis  
models  in  rats.  Three  experimental  acute  pancreatitis  models  which  resemble  the  clinical  
disease  were  used.  Edematous  pancreatitis  was  induced  by  subcutaneous  injections  of  
cholecystokinin-octapeptide  (CCK)  (3).  Necrohemorrhagic  pancreatitis  was  induced  by  
retrograde  infusion  of  sodium  taurocholate  (TC)  into  the  pancreatic  duct  (4).  Necrotizing  
pancreatitis was induced by intraperitoneal injections of L-arginine (Arg) (5-6).  
HSPs  were  first  discovered  40  years  ago  by  Ritossa  (7).  The  HSPs  are  a  group  of  
highly  conserved,  ubiquitous  and  functionally  related  proteins  that  play  an  essential  part  in  
cell  survival  (8,9).  Cells  subjected  stress respond  by  synthesising  HSPs.  The  induction of the 
heat shock response  enhances the ability of the cells to  overcome the effects of the stress (9). 
Following  the  development  of  stress  conditions,  many  cellular  proteins  become  partially  or  
completely  denatured  or malfolded.  HSPs  recognize  this,  bind to the  damaged  proteins,  and  
stabilize  and refold them, thereby preventing  or dissolving  otherwise irreversible  aggregation.  
The  HSPs  are  well  known  to  protect  cells  against  stress  (9-11).  HSPs  are  also  necessary  
during normal  physiological  conditions  since they  are  involved  in the  synthesis,  degradation,  
folding,  transport  and  translocation  of  proteins,  and  the  assembly  and  disassembly  of  
oligomers (9).  HSPs  are divided into different families,  according to their molecular size (e.g.  
HSP60 and HSP70)  (12).  The HSP families have several  functional homologs  in the different 
compartments of cells.  HSP60 is primarily a mitochondrial  protein,  but it can also be found in 
the pancreatic  zymogen  granules  (13).  The  HSP70  family  of  HSPs is  perhaps  the  most  well  
studied.  The  HSP70  family  members  include  the  highly  stress-inducible  HSP72  and  the  
constitutively  expressed  HSP73  in the cytoplasm,  the  mitochondrial  HSP75,  and the  GRP78  
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(glucose-regulated  protein)  in  the  endoplasmic  reticulum  which  is  also  referred to  as  heavy  
chain immunoglobulin binding protein (BiP) (12). HSPs  are expressed constitutively  and/or at 
elevated  levels  upon  the  exposure  of  cells  to  a  variety  of  stress  conditions  in  every  organ,  
including the pancreas (14). 
In  addition  to  causing  pancreatitis,  dibutylin  dichloride,  L-arginine,  and  
supramaximally  stimulating doses of cerulein  act  as stressors  and have been shown to  induce 
expression of  HSPs  in  the  pancreas  (16,23,26-28).  In  contrast,  Strowski  et  al.  demonstrated  
that cerulein pancreatitis  in itself increases mRNA but paradoxically reduces protein levels of 
rat  pancreatic  HSPs  (29).  These  observations  even  suggest  that  the  low/high  levels  of  
pancreatic  HSPs  might  be  involved  in  the  development/amelioration  of  cerulein-induced  
pancreatitis.  For the above-mentioned  reasons,  it may be  speculated that the administration of 
HSP-inducer  compounds  during  CCK-induced  pancreatitis  should  ameliorate  the  severity  of  
the disease.  However,  the main problem regarding HSP induction is that the HSPs  are mostly 
induced by harmful conditions.  The real challenge is to upregulate HSP synthesis without any 
toxic side-effects. 
It  has  been  demonstrated  that  the  preinduction  of  HSP  expression  has  a  protective  
effect against cerulein-and dibutylin dichloride-induced pancreatitis  in rats or against choline-
deficient  ethionine-supplemented  diet  model  pancreatitis  in  mice  (15-23).  However,  the  
conclusions  drawn  from  these  experiments  are  somewhat  controversial.  Lee  et  al.  (19)  and  
Otaka et al.  (20)  found that the protective effect against this acute pancreatitis model was due 
to  the  specific  preinduction  of  pancreatic  HSP60  (by  CWI),  while  Wagner  et  al.  (21)  and  
Frossard  et  al.  (17)  attributed  it  to  pancreatic  HSP72  (induced  by  hyperthermia,  HWI).  
Convincing  evidence  of  the  protective  effects of  pancreatic  HSP72  against  cerulein-induced  
pancreatitis was provided  by Bhagat  et  al. just  recently  (16).  Nevertheless,  the mechanism of  
how  HSPs  protect  against  CCK-induced  pancreatitis  remains  to  be  answered.  The  
cytoprotective effects of the HSPs on other (more serious)  acute pancreatitis models have not 
been investigated. 
Water immersion stress results in a number of stress-induced responses,  like metabolic  
alterations  and the  synthesis  of  a variety  of  proteins  besides  HSP60  and HSP72,  which may 
have  protective  roles  in  the  prevention  of  a  subsequent  stress.  For  example,  the  antioxidant  
enzymes  catalase  and  manganese  superoxide  dismutase  (SOD)  can  also  take  part  in  the  
protective effect (24,25).  Therefore, (besides HSPs) we also examined the levels of pancreatic 
antioxidants  after  the  water  immersion  stress.  To  bypass  the  confounding  effects  of  the  
changes in the body temperature,  rats were administered SA (IV) and BRX-220 (V). 
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2. MATERIALS AND METHODS 
2.1. Animals. 
Male Wistar rats weighing 250-350  g were used.  The animals were housed in standard 
cages  at a constant room temperature of 25  °C with a  12-h light-dark cycle,  and were allowed 
free  access  to  water  and  standard  laboratory  chow  (Biofarm,  Zagyvaszántó,  Hungary).  The  
rats  were  randomly  assigned  to  control  of  experimental  groups  and  were  fasted  overnight  
before  the  induction  of  acute  pancreatitis.  The  experiments  performed  in  this  study  were  
approved by the Animal  Care Committee of the University of Szeged. 
2.2. Production of HSP60  antibody.  
Antibody against HSP60 was produced  in rabbit by an intramuscular injection of  1 mg 
of protein emulsified in Freund's complete  adjuvant.  Booster shots were given three times in 
Freund's incomplete  adjuvant in a similar  manner  at 2-week  intervals.  The rabbit was  bled 1 
week  after  the  last  injection.  The  antibody  was  purified  by  affinity  chromatography  on  a  
protein A-  Sepharose  column.  The  specificity  of  the  antibody  was  checked  on  rat  pancreas  
homogenates  and on bacteria overexpressing  rat HSP60. 
2.3. Induction of  HSPs.  
2.3.1. Cold- and hot-water immersion  stress.  
The rats were anesthetized with pentobarbital  (PB) (44 mg/kg)  intraperitoneally  (i.p.).  
Water  immersion  stress  was  performed  according  to  Otaka  et  al.  (20)  with  some  
modifications.  In group C  [CWI] (n=24),  the  rats  were  immersed  vertically  in a 23  °C water 
bath  to  the  depth  of  the  xiphoid  process  for  6  h.  When  the  animals  woke  up  from  the  
anaesthesia,  they were immediately  reanaesthetized with 22 mg/kg PB i.p.  In group H [HWI] 
(n=24),  the  rats were  immersed  vertically  in  a 37  °C water  bath,  and the  water  temperature  
was then gradually increased to 42 °C (during  55 min)  and maintained there for 20 min (total  
1 h  15  min).  The  rectal  temperature  of  4-4  animals  was  monitored  during the  CWI  or HWI 
every  10 minutes  by  a digital  thermometer  (Omker,  Budapest,  Hungary)  to  demonstrate  the  
actual time-body temperature history of the rats. 
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In  order  to  evaluate  the  expressions  of  HSP60,  and  HSP72  after  the  CWI  or  HWI  
stress, 4  rats were killed at each time point before (to), immediately  after (0),  or 3, 6, 9  or 12 h 
after the end of the immersion.  The pancreas was quickly  removed,  cleaned of  fat and lymph 
nodes,  and frozen at -70  °C until processing. 
2.3.2. Sodium arsenite  injection.  
Twenty-eight  rats were injected i.p. with progressive doses of SA (2 to  14 mg/kg body 
weight  [b.w.])  [Merck, Darmstadt,  Germany] to investigate the SA dose response.  The control 
animals  (n=4)  received  physiological  saline  injection  i.p.  The  animals  were  killed  by  
exsanguination through the abdominal  aorta  12 h after the injections.  The pancreas  and lungs 
were quickly  isolated  and frozen at -70  °C until the  Western blot analysis was performed.  In  
order to evaluate the time-course  response of the expressions of HSP60  and HSP72,  the least 
toxic  SA dose producing a high amount of HSP was chosen.  A  group of 32 animals received 
10 mg/kg b.w. of  SA i.p.  and were killed  at different time-points  after the injection (3-48  h).  
The  control  animals received  a saline  injection  i.p.  and were  killed  after  12 h.  The pancreas  
and lungs were processed for HSP determinations. 
2.3.3. Administration  of BRX-220. 
Rats  were  administered  20  mg/kg  BRX-220  {(+)-/R/-N-[2-hydroxy-3-(l-piperidinyl)-
propoxy]-pyridine-l-oxide-3-carboximidoil-chloride  (Z)-maleate  (1:1),  BIOREX  Research  
and Development Co., Veszprem-Szabadsagpuszta,  Hungary}  intragastrically.  
2.4. Induction of acute  pancreatitis.  
Acute pancreatitis was induced near the peak of the HSP synthesis by the following methods: 
CCK-inducedpancreatitis.  Edematous pancreatitis was induced by injecting 75  pg/kg  
body weight (b.w.)  CCK (synthetized by Penke et al.,  Dept. of Medical  Chemistry, University 
of Szeged) subcutaneously (s.c.) three times at intervals of 2 h. 
TC-induced pancreatitis.  100  pi/100  g  b.w.  3%  TC  (Sigma-Aldrich,  St.  Louis,  MO,  
USA) was injected into the common biliopancreatic  duct under steady manual pressure over a 
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period  of  30  seconds  as  described  by  Aho  et  al.  (4).  All  injections  were  performed  by  the  
same investigator  to  limit technical differences. 
Arg-inducedpancreatitis.  Necrotizing  acute  pancreatitis  was  induced  by  injecting 230 
mg/100  g b.w. Arg (Sigma-Aldrich,  St. Louis,  MO, USA)  i.p. twice  at an interval of  1 h. 
2.5. Experimental  protocol.  
2.5.1.  The  effects  of  cold-  and  hot-water  immersion  pretreatment  on  experimental  acute  
pancreatitis  models  (ITII).  
In every  group, the rats were anesthetized  with  PB  (44 mg/kg)  i.p.  at the  starting  point  
of the experiment  (t0).  
CCK-inducedpancreatitis  (Fig. 1).  In  group CC  [CWI + CCK]  (n=6), the rats  received  
the  CCK  immediately  after  the  CWI.  In  group  0 C C  [No  CWI  +  CCK]  (n=6),  the  animals  
were  kept  at  room  temperature  and  were  injected with  CCK  at  t0  +  6, t0  +  8 and  t0  +  10 h.  In  
group  HC  [HWI  +  CCK]  (n=6),  the  rats  received  CCK  as  mentioned  above,  following  a  6-h 
recovery  period  after  the  HWI.  In  group  0 H C  [No  HWI  +  CCK]  (n=6),  the  rodents  were  
given  CCK starting  at t0 + 7 h  15 min. 
PB  PB  CCK  CCK  CCK  
A.  |  1  1  1  I  
Group  CC  WI 23 °C, 6  h  
Group  0 C C  | 
0 W I  23 °C, 6  h  
B. 
to 
PB 
I 
Lh tfch  tab  
t 
i 
t|Oh  tl2h  
CCK  CCK  CCK  
I  I  I  
Croup  HC  
Group  0 H C  
WI  42 °C 
1  h  15'  6  h  recovery  
0 W I  42  °C 1  1  
1 h  15'  
to t l h l S ' 
Fig.  1.  Experimental  protocol  -  CCK-
induced  pancreatitis.  In  every  group,  the  
rats  were  anesthetized  with  44  mg/kg  body  
weight  (b.w.)  pentobarbital  (PB)  
intraperitoneally  (i.p.)  at  the  starting  point  
of  the  experiment  (t0).  A.  Group  CC:  the  
rats  received  75  pg/kg  b.w.  cholecysto-
kinin-octapeptide  (CCK)  subcutaneously  
three  times  at  intervals  of  2  h  immediately  
after  the  cold-water  immersion  (CWI).  
Group  0 C C :  the  animals  were  kept  at  
room  temperature  and  were  injected  with  
CCK  at  t0  +  6,  t0  +  8  and  t0  +  10  h.  B.  
Group  HC:  the  rats  received  CCK  as  
mentioned  above,  following a 6-h  recovery  
period  after  the  hot-water  immersion  
(HWI).  Group  0 H C :  the  rodents  were  
given  CCK,  starting  at t0 +  7  h  15 min.  The  
animals  were  killed  (+)  2  h  after  the  last  
CCK  injection.  
TC-induced  pancreatitis  (Fig.  2).  In  group  CT  [CWI  +  TC]  (n  =  6),  the  rats  received  
the TC  immediately  after the  CWI.  In group 0 C T  [No  CWI  + TC]  (n  =  6),  the  animals  were  
kept  at  room  temperature  and  were  injected  with  TC  at  t0  +  6  h.  In  group  HT  [HWI  +  TC]  
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(n=6),  the  rats  received  TC  as  mentioned  above,  following  a  6-h  recovery  period  after  the  
HWI.  In group 0 H T  [No HWI  + TC] (n=6), the rodents were  given TC  at t0 +  7 h  15 min. 
A. 
Group  CT  
Group  S C T  
PI) 
4 
PB  TC  
4  4  
tj» u» 
B. 
PB 
4 
TC 
I 
to ihir Ellis' 
t 
1 
WI  23 'C,  6  h  j 
0YVI 23 'C, 6 h 
t I2h 
I 
WI  42  'C  
Group  HT  1  h  15'  6 h recove rv  ,  w  
0 W I 4 2  *C  1  'P  
Group  0 H T  1  h  15'  
Fig.  2.  Experimental  protocol  -  TC-induced  
pancreatitis.  In  every  group,  the  rats  were  
anesthetized  with  44  mg/kg  b.w.  PB  i.p.  at  
the  starting  point  of  the  experiment  (t0).  A.  
Group  CT:  100  pl/100  g  b.w.  3%  sodium  
taurocholate  (TC)  was  injected  into  the  
common  biliopancreatic  duct  under  steady  
manual  pressure  over  a period  of 30  seconds  
as  described  by  Aho  et  al.  (4)  immediately  
after  the  CWI.  Group  0 C T :  the  animals  
were  kept  at  room  temperature  and  were  
injected  with  TC  at  t0  +  6  h.  B.  Group  HT:  
the  rats  received  TC  as  mentioned  above,  
following  a  6-h  recovery  period  after  the  
HWI.  Group  0 H T :  the  rodents  were  given  
TC  at  t0  +  7  h  15  min.  The  animals  were  
killed  (+)  6 h after the TC  injection.  
'Uh!5 
Arg-inducedpancreatitis  (Fig.  3).  In  group  CA  [CWI  + Arg]  (n =  6), the rats  received  
the Arg immediately  after the CWI.  In group 0 C A  [No CWI + Arg] (n =  6), the animals  were  
kept  at room temperature  and were injected with Arg  at t0 +  6 and t0 +  7 h.  In group HA  [HWI  
+  Arg]  (n=6),  the  rats  received  Arg  at  6  and  7  h  after  the  HWI.  In  group 0 H A  [No  HWI  +  
Arg]  (n=6), the rats were given Arg starting  at t0  +  7 h  15 min. 
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Arg  Arg  
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tjih 
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4 
WI  42 °C 
1  h  15'  ft Ii  recovery  1  / 7  0 W I  42  "C  
1  h  15'  
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Fig.  3.  Experimental  protocol  -  Arg-induced  
pancreatitis.  In  every  group,  the  rats  were  
anesthetized  with  44  mg/kg  b.w.  PB  i.p.  at  the  
starting  point  of the  experiment  (t0).  A.  Group  
CA:  the  rats  received  L-arginine  (Arg)  (2  x  
230  mg/100  g  b.w.  at  a  1-h  interval  i.p.)  
immediately  after  the  CWI.  Group  0 C A :  the  
animals  were  kept  at  room  temperature  and  
were  injected  with  Arg  at  t0  +  6  and  t0  +  7  h.  
B.  Group  HA: the  rats  received  Arg  at  6  and  7  
h  after  the  HWI.  Group  0 H A :  the  rats  were  
given  Arg,  starting  at  t0  +  7  h  15  min.  The  
animals  were  killed  (+)  24  h  after  the  second  
Arg  injection.  
<u tlblS* ft  III 5'  tjj | | | 5 ' tjlhl.V 
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The animals were  killed  by exsanguination  through the abdominal  aorta  2  h after the  last  CCK  
injection,  6  h after the TC  injection,  or  24  h  after the  second  Arg  injection. The  pancreas  was  
quickly removed,  cleaned  from fat and  lymph nodes,  weighed,  and frozen at - 7 0  °C until  use.  
2.5.2.  The  effect  of  sodium  arsenite  pretreatment  on  CCK-induced  acute  pancreatitis  
(Fig.  4,  IV).  
In  groups  AC-2  (n=6)  and  AC-6  (n=6)  [SA  +  CCK],  the  rats  were  injected  with  10  
mg/kg  of  SA  i.p.,  and then  received  CCK  s.c.,  starting  at  9 h after the  SA injection.  In  groups  
SC-2  (n=6)  and  SC-6  (n=6)  [saline  +  CCK],  the  animals  were  injected  with  physiological  
saline  i.p.  instead  of  SA,  and  the  3  x  75  pg/kg  b.w.  CCK  was  administered  after  9  h  (Fig.  
1/B).  The  animals  were  killed  by  exsanguination  through  the  abdominal  aorta  2  or  6  h  after  
the  last  CCK  injection,  as  indicated  by  the  number  after  the  dash  in  the  group  names.  The  
pancreas  and  lungs  were  quickly  removed,  cleaned  of  fat  and  lymph  nodes,  weighed,  and  
frozen at - 7 0  °C until  use.  
A r s e n i t e  ( G r o u p  A C - 2 ,  A C - 6 )  A C / S C - 2  A C / S C - 6  
P h y s .  S a l i n e ( G r o u p  S C - 2 ,  S C - 6 )  C C K  C C K  C C K  t  t  
I  #  1  I  i  I  
9  1»  r e c o v e r y  
H  1  
t'0  *!>!>  t i l l ,  t j 3|,  t | 5 | ,  t |9 | .  
Fig.  4.  Experimental  protocol.  In  groups  AC-2  (n=6)  and  AC-6  (n=6)  [SA  +  CCK],  the  rats  were  injected  with  
10 mg/kg  of  sodium  arsenite  (SA)  i.p.  at  the  beginning  of  the  experiment  (t0),  and  then  received  75  pg/kg  b.w.  
CCK  s.c. three  times  at  intervals  of 2  h, starting  at  9  h (t9) after the  SA  injection.  In groups  SC-2  (n=6)  and  SC-6  
(n=6)  [saline  +  CCK],  the  animals  were  injected  with  physiological  saline  i.p.  instead  of  SA,  and  the  3  x  75  
pg/kg  b.w.  CCK  was  administered  after  9  h.  The  rats  were  sacrificed ( t )  2  or  6  h after the  last  CCK  injection  as  
indicated  by the number  after the  dash  in the group  names.  
2.5.3. The  effect of BRX-220  on CCK-induced  acute  pancreatitis  (V).  
In  group  B  (n=6),  20  mg/kg  BRX-220  (dissolved  in  physiological  saline)  was  
administered  intragastrically,  followed  by  75  pg/kg  CCK  s.c.  three  times,  after  1,  3  and  5  h.  
This  whole  procedure  was  repeated  for  5  days.  The  aminals  in  group  0 B  (n=6)  received  
physiological  saline  intragastrically  instead  of  BRX-220,  but  otherwise  the  protocol  was  the  
same  as  in  group  B.  The  animals  were  sacrificed  by  exsanguination  through  the  abdominal  
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aorta 12 h after the last CCK injection.  Three untreated rats ( 0 )  were killed for HSP60 and 72 
determinations.  The  pancreas  was  quickly  removed,  cleaned  from  fat  and  lymph  nodes,  
weighed, and frozen at -70  °C until use. 
2.6. Assays. 
Pancreatic  weight/body  weight  ratio  (pw/bw).  Pancreatic  weight  was  divided  by  the  
body weight of the rat. This ratio was utilized to evaluate the degree of pancreatic edema. 
Serum amylase  activity  and plasma trvpsinogen  activation  peptide  concentration.  All  
blood  samples  were  centrifuged  at  2500g  for  30  min.  The  serum  levels  of  amylase  were  
determined  by  a  colorimetric  kinetic  method  (Dialab,  Vienna,  Austria).  Plasma  trypsinogen  
activation peptide  (TAP) concentrations were determined with an ELISA kit (Biotrin,  Dublin,  
Ireland) according to the manufacturer's instructions. 
Serum  cytokine  concentrations.  TNF-a  levels  were  titrated  in  a  bioassay  on  the  
WEHI-164 cell  line  (30).  IL-6 concentrations  were  measured via their proliferative  action on 
the IL-6-dependent mouse hybridoma cell line B-9 (31). The activities were calibrated against 
recombinant  TNF  (Genzyme,  Cambridge,  UK)  and  recombinant  IL-6  (Sigma-Aldrich,  
Munich, Germany).  IL-1J3 concentrations were determined with an ELISA kit (R&D  Systems,  
Minneapolis, MN) according to the manufacturer's instructions. 
Pancreatic  contents  of  amylase,  trvpsinogen.  lipase,  DNA  and protein.  A  part of  the  
pancreas  was  homogenized  in  9 vol  of  ice-cold  buffer containing  0.02  M Tris-HCl,  pH 7.8,  
0.15 M NaCl  0.1% Triton X-100. Enzyme measurements were  carried  out on the  supernatant  
fractions  of  the  pancreatic  homogenates.  Pancreatic  amylase  activities  were  determined  as  
described above.  Trypsinogen was activated after a 200-fold dilution of the homogenate  with  
0.02 U enterokinase/pg pancreatic protein (Sigma,  St. Louis, MO, USA) in the enzyme buffer 
containing  80 mM Tris-HCl,  pH 8.0,25  mM CaCl2  and  100 pg/ml bovine  serum albumin for 
120 min at 37 °C (32).  Lipase activities were measured by a pH-stat method (32).  Samples for 
DNA  determination  were  precipitated  with  ice-cold  0.8  M  perchloric  acid,  washed  in  5%  
trichloroacetic  acid,  and then hydrolyzed with 0.8 M perchloric  acid at 90 °C for  10 min (33). 
DNA was  estimated  photometrically  with diphenylamine  (34).  The protein  concentrations  in  
the supernatant fractions of the homogenates were measured by the method of Goa (35). 
Pancreatic  lipid peroxidation,  carbonvl  protein and reduced  glutathione levels,  and the 
activities of superoxide dismutase. catalase and glutathione peroxidase.  The remaining part of 
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the  pancreas  was  homogenized,  the  homogenates  centrifuged  at  3000g  for  10  min,  and  the  
supernatants  were  used  for  measurements.  Lipid  peroxides  can  undergo  metal-  or  enzyme-
catalyzed  decomposition  to form multiple  products,  including  malondialdehyde  (MDA).  The  
pancreatic  MDA  level  was  measured  after the  reaction with thiobarbituric  acid,  according  to  
the  method  of  Placer  et  ál.  (36)  or  according  to  the  MDA/TBA-high  performance  liquid  
chromatographic  (HPLC)  method  of  Wong  et  ál.  (37),  and  was  corrected  for  the  protein  
content of  the tissue  (35).  The HPLC assay  is  more specific,  sensitive  and reproducible  than  
spectrophotometric  techniques  (37).  The  concentration  of  protein  carbonyls  was  determined  
by  the  2,4-dinitrophenylhydrazine  reaction  according  to  the  method  of  Levine  et  ál.  (38).  
Carbonyl protein content was calculated by using the absorption coefficient of 22,000  M^cm'1  
at  370  nm  for  aliphatic  hydrazones  and  expressed  as  nmol  carbonyl/mg  protein.  Reduced  
glutathione  (GSH)  level  was  determined  spectrophotometrically  with Ellman's  reagent  (39).  
Superoxide  dismutase  (SOD)  activity  was  determined  on  the  basis  of  the  inhibition  of  
epinephrine-adrenochrome  autooxidation  (40).  Mn-SOD  activity  was  measured  by  the  
autooxidation  method  in  the  presence  of  5  x  10"3  M  KCN  (41).  Cu/Zn-SOD  activity  was  
calculated  by  substracting  the  activity  of  Mn-SOD  from SOD  activity.  Catalase  activity  was  
measured  spectrophotometrically  at  240  nm  by  the  method  of  Beers  and  Sizer  (42)  and  
expressed  in  Bergmeyer  units  (BU)  (1  BU  =  decomposition  of  1  g  H202/min  at  25  °C).  
Gluthathione  peroxidase  (GPx)  activity  was  determined  according  to  the  chemical  method,  
using cumene hydroperoxide and GSH as substrates of GPx (43). 
Western  blotting.  A  part  of  the  pancreas  was  homogenized  in  the  previously  
mentioned  homogenizing  buffer  supplemented  with  the  protease  inhibitors  1  mM  PMSF,  4  
mM  benzamidine,  5  mM  iodoacetamide  and  100  IU/ml  aprotinin  using  an  Ultra-Turrax  
homogenizer  for  2.5  min.  The  homogenates  were  centrifuged  at  20,000g  for  30  min.  The  
supernatants  were  collected  and  the  protein  concentrations  were  measured  as  mentioned  
before  (35).  Twenty  micrograms  of  protein  was  loaded  per  lane.  Samples  were  
electrophoresed on an 8% sodium dodecylsulfate-polyacrylamide  gel according to the method 
of Laemmli  (44),  and transferred to nitrocellulose  membrane for 2.5  h at 30 V  or stained with 
Coomassie  Brilliant  blue  (to  check  equal  loading  of  proteins  for  Western  blot  analysis).  
Membranes  were  blocked  in  5%  nonfat  dry  milk  for  1  h,  and  incubated  with  rabbit  anti-
HSP60  (1:10,000  dilution)  or  anti-HSP72  (1:2,500  dilution)  (a  generous  gift  from  István  
Kurucz,  Biorex  Laboratories,  Veszprém,  Hungary,  which  has  been  characterized  previously  
[45])  antibody  for  1 h  at room  temperature.  The  immunoreactive  protein  was  visualized  by  
enhanced  chemiluminescence,  using  horseradish  peroxidase-coupled  anti-rabbit  
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immunoglobulin  at  1:10,000  dilution  (Dako,  Denmark).  The  densities  of  the  bands  were  
quantitated  by  using  an  A.A.B.  Image  Analysis  Program  (Advanced  American  
Biotechnology,  Fullerton,  CA).  
Lung  myeloperoxidase  activity.  Lung  myeloperoxidase  activity,  as  a marker  of  tissue  
leukocyte  infiltration, was determined  by the method  of Kuebler  et  al.  (46).  
2.7. Histological  examination.  
2.7.1. Light  microscopy.  
A 2-3 mm3  portion  of the  pancreas  was  fixed  in  an  8% neutral  formaldehyde  solution  
and  subsequently  embedded  in paraffin. Sections were  cut  at  4  pm thickness  and  stained  with  
hematoxylin  and  eosin. The slides were  coded  and read  for the traditional  histological  markers  
of pancreatic  tissue  injury  by two  independent  observers  who  were  blind  to  the  experimental  
protocol.  Semiquantitative  grading  of  interstitial  oedema,  leukocyte  infiltration  and  
adherence,  vacuolization,  necrosis,  and apoptosis  of acinar  cells  (Fig.  5), was performed on  8-
10 consecutive  high-power  fields (x400)  on  a  scale  of  0-3  or  0-4  (described  in more  detail  in  
Table  1).  In  addition,  basophilic  lamellation  of  the  cytoplasm  of  acinar  cells  was  also  graded  
(Fig.  5/E)  since  a pilot  study revealed  that  besides  the traditional  markers,  areas  of  basophilic  
lamellation  were  more  extensive  in the  more  severely  damaged  pancreata.  The  score  for  each 
graded  parameter  was  averaged  and  the total  pancreatic  damage  was  calculated  by  adding  all  
the averages  together.  
T a b l e t .  His tological  g rad ing  system  fo r  the  e v a l u a t i o n  of  cho lecys tok in in -oc tapep t ide -
i n d u c e d  acu te  pancreat i t i s  in  rats .  S c o r i n g  w a s  p e r f o r m e d  on  8 - 1 0  consecut ive  high-
p o w e r  fields  (400x) .  T h e  score  for each  g r a d e d  p a r a m e t e r  was  averaged  a n d  the  tota l  
p a n c r e a t i c  d a m a g e  was  ca lcu la ted  by  a d d i n g  all  the  averages  together .  
Scores 
0 1 2 3  4  
Interst i t ia l  o e d e m a  0 mild m o d e r a t e severe 
L e u k o c y t e  infiltr.  (no.  of  cells)  0 - 1 2 - 5 6 1 0 > 1 0 
Leukocy t e  a d h .  (no .  of  cells)  0 1 2 - 3 > 3 
Vacuo l i z a t i on  {%  of  total  ac inar  cells)  0 1 - 3 3 3 4 - 6 6 6 7 - 1 0 0 
Necros i s  ( %  of  total  ac inar  cells)  0 1 - 2 5 26 -50 51  75  76 -100  
A p o p t o s i s  ( n o .  of  apop to t i c  bodies)  0 - 1 2 - 5 6 - 1 0 > 1 0 
Basoph .  l am.  ( %  of  total  ac inar  cells)  0 1 - 3 3 34  66  6 7 - 1 0 0 
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2.7.2.  Electron  microscopy.  
For  electron microscopic  observations,  1 mm3 pieces  of the pancreas  were  fixed in  3%  
phosphate-buffered glutaraldehyde.  Tissue blocks were postfixed  in  1% OsCU, and then  rinsed  
in distilled  water,  dehydrated  in  a graded  series  of  ethanol,  and  embedded  in TAAB  Transmit  
Resin  (TAAB,  England).  Ultrathin  sections  were  double-stained  with  uranyl  acetate  and  lead  
citrate  and examined  with  a Philips electron  microscope.  
2.8. Statistical  analysis.  
Results  are  expressed  as  means  ±  SEM.  Experiments  were  evaluated  by  using  the  
Student's  t-test  when  the  data  consisted  of two  groups,  or  by  analysis  of variance  when  three  
or more groups were compared. Values of p  < 0.05 were  accepted  as significant. 
Fig. 5.  Morphological  features  of  experimental  acute  pancreatitis  in  rat.  The  features  include  A.,  B.  interstitial  
oedema  (asterisk),  necrosis  of  pancreatic  acinar  cells  (plus),  C.  adherence  of  leukocytes  to  the  endothelium  of  
venules  (arrows),  D.  vacuolization  of  acinar  cells  (arrow),  E.  basophilic  lamellation  of  the  cytoplasm  of  acinar  
cells  (arrows),  and  F.  apoptosis  of  acinar  cells  (arrow)  (hematoxilin  and  eosin,  original  magnifications  were  
changed  during  image  processing).  
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3. RESULTS 
3.1. Specificity  of the  HSP60  antibody.  
The specificity of the HSP60 antibody  is shown  in Fig.  6. Only the 60 kD band was  stained.  
Fig.  6.  Specificity  of  the  home-made  HSP60  
antibody.  The  Figure  shows  a  picture  of  a  
Western  blot  in  which  a  60  kD  protein  band  is  
stained  both  in  the  pancreas  homogenate  of  an  
untreated  rat ( 0 )  and  in  the  protein  extract  (PE)  
of  bacteria  overexpressing  rat  HSP60.  20  
micrograms  of  protein  was  loaded  per  lane.  
Samples  were  separated  on  an  8%  sodium  
dodecylsulfate-polyacrylamide  gel  according  to  
the  method  of  Laemmli  and  transferred  to  
nitrocellulose  membrane  for  2.5  h  at  30  V.  The  
nitrocellulose  membrane  was  blocked  in  5%  
nonfat  dry  milk  for  1 h,  and  was  incubated  with  
rabbit  anti-HSP60  (1:10,000  dilution)  for  1  h.  
The  immunoreactive  protein  was  visualized  by  
enhanced  chemiluminescence,  using  a  
horseradish  peroxidase-coupled  anti-rabbit  
immunoglobulin  at  1:10,000  dilution  (Dako,  
Denmark). 
Cont ro l  0  
Con t ro l  0  
1.0  1  I  1  1  
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Fig.  7.  Effect  of  water  immersion  stress  on  pancreatic  
HSP  synthesis.  Representative  Western  immunoblots  
of protein  lysates  (20  pg/lane)  extracted  from  pancreata  
harvested  over  a time  course  after the  water  immersion  
treatments  (0-12  h).  The  control  did  not  receive  any  
treatment.  A.  Expression  of  pancreatic  HSP72  after  
HWI.  HSP72  could  not  be  detected  in  the  unstressed  
control,  but  its  expression  was  significantly  increased  
at  3  h  after the  HWI  and  remained  elevated  until  12  h.  
B.  Expression  of  pancreatic  HSP60  after  CWI.  The  
diagram  shows  the  relative  density  of the  HSP60  bands  
[density  at  each  time  point/density  before  WI  stress  
(control)]  vs  the  time  after  the  CWI  treatment  as  
analysed  by  densitometry.  The  maximal  amount  of  
HSP60  was  noted  immediately  after  the  end  of  the  
immersion  (0),  and  the  levels  remained  significantly  
elevated  over  the  next  9  h.  Values  are  means  ±  SEM  
for  4  animals  at  each  time  point.^Significant  
difference (p  < 0.05)  vs the unstressed  control  group.  
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3.2. Induction of  HSPs.  
3.2.1. Cold- and hot water immersion  stress.  
HSP72  could  not  be  detected  in  the  unstressed  control,  but  its  expression  was  
significantly  increased  at  3  h  after  the  HWI  and  remained  elevated  until  12  h  (Fig.  7/A).  
HSP60 is constitutively expressed in the pancreas, HWI did not have a significant effect on its 
expression (data not shown).  The levels of HSP72 after CWI did not differ significantly from 
the  control  (data  not  shown),  but  the  expression  of  HSP60  increased  significantly  during  
CWI.  The  maximal  amount  of  HSP60  (as  compared  to  the  unstressed  control)  was  noted  
immediately  after the  end  of  the  immersion,  and  the  levels  remained  significantly  elevated  
over  the  next  9  h  (Fig.  7/B).  The  body  temperature  of  rats  during  CWI  and  HWI  stress  is  
shown in Annex No.  I.  
3.2.2. Sodium arsenite  injection.  
The  progressive  doses  of  SA  produced  an  increased  expression  of  HSP72  in  the  
pancreas  and  lungs  (Fig.  8).  The  time-course  of  HSP72  expression  after  SA  treatment  was  
obtained  by using the  10 mg/kg b.w.  dose.  HSP72 was  already significantly increased  at 3 h, 
peaked  at 9-24 h after the  SA injection  and remained elevated until  48 h in both organs  (Fig.  
9). HSP60 is constitutively  expressed in the pancreas  and lungs.  HWI  and SA  did not have a 
significant effect on its expression (results not shown).  A 25% mortality  rate was observed in  
the  group of  animals  that received  14 mg/kg  b.w.  of  SA.  Moreover,  most  of  the  animals  in  
this group appeared lethargic  and anorectic. No mortality occurred at lower doses of SA. 
3.2.3. Administration  of BRX-220. 
The expressions  of  pancreatic  HSP60  and HSP72  were  significantly  decreased  in the 
animals  with  pancreatitis  (B, 0B)  vs  the  untreated  animals ( 0 ,  not receiving  BRX-220  and  
CCK)  (Fig.  10).  In  group  B,  pancreatic  HSP60  (1.8  x)  and  HSP72  (2.9  x)  levels  were  
significantly increased vs  group 0B  (Fig.  10).  
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Fig.  8.  Effects  of  progressive  doses  of  SA  injection  
on  the  synthesis  of  HSPs  in  the  pancreas  and  lungs.  
The  Figure  depicts  representative  Western  
immunoblot  analysis  of  protein  lysates  (50  pg/lane)  
from  A.  the  pancreata  and  B.  the  lungs  of  rats,  
showing  the  expression  of  HSP72  after  the  injection  
of  progressive  doses  of  SA.  Twenty-eight  animals  
were  injected  i.p.  with  progressive  doses  of  SA  (2  to  
14  mg/kg  b.w.)  [Merck,  Darmstadt,  Germany];  the  
control  rats  [0]  (n=4)  received  a  physiological  saline  
injection  i.p.  The  rats  were  sacrificed  12  h  after  the  
injection,  and  the  pancreas  and  lungs  were  quickly  
isolated  and  frozen  at  - 7 0  °C  for  Western  blot  
analysis.  HSP72  could  not  be  detected  in  the  control  
group,  but  progressive  doses  of  SA  produced  an  
increased  expression  of  HSP72  in  the  pancreas  and  
lungs.  HSP60  was  constitutively  expressed  in  the  
pancreas  and  lungs,  SA  did  not  have  a  significant  
effect  on  its  expression.  A  25%  mortality  rate  was  
seen  in  the  group  of  animals  that  received  14  mg/kg  
b.w.  of  SA.  
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Fig.  9.  Effects  of  SA  injection  on  the  synthesis  of  
HSPs  in  the  pancreas  and  lungs  as  a  function  of  
time.  Representative  Western  immunoblot  analysis  
of  protein  lysates  (50  pg/Iane)  from  A.  the  
pancreata  and  B.  the  lungs  of  rats,  showing  the  
expression  of HSP72  as  a function of  time  after  SA  
injection.  A group  of 32 animals  were  injected  with  
10  mg/kg  b.w.  of  SA  i.p.  and  were  killed  at  
different  time-points  after  the  injection  (3-48  h).  
The  control  animals  (0)  (n=4)  received  a  
physiological  saline  injection  i.p.  and  were  killed  
after  12  h.  HSP72  could  not  be  detected  in  the  
control  group,  but  its  expression  was  already  
significantly  increased  at  3  h  and  peaked  at  9-24  h  
after  the  SA  injection,  and  remained  elevated  until  
48  h  in  both  organs.  HSP60  was  constitutively  
expressed  in  the  pancreas  and  lungs,  SA  did  not  
have  a  significant  effect  on  its  expression  (results  
not  shown).  
3.3.  Pancreatic  reduced  glutathione  level,  and  the  activities  of  glutathione  
peroxidase,  superoxide  dismutase  and  catalase  after  cold-  and  hot-water  
immersion  stress  
Both  HWI  and  CWI  significantly  decreased  the  pancreatic  GSH  content,  and  the  
activities  of  GPx,  Mn-SOD,  Cu/Zn-SOD  and  catalase  immediately  after the  end  of  the  water  
immersion treatment  (as compared  to the unstressed  control).  Only the activity  of  Cu/Zn-SOD  
recovered  soon  after  the  CWI  (3  h).  The  level  of  other  antioxidants  after  water  immersion  
remained  significantly decreased throughout  the examined time period  (see Annex No.  III).  
3.4. The effects  of  cold-  and  hot-water  immersion  pretreatment  on  experimental  
acute  pancreatitis  models  (l-III).  
The  administration  of  CCK,  TC  or  Arg  induced  the  typical  laboratory  and  
morphological  changes  of acute pancreatitis  (3-6).  
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Fig.  10. Western  blot  analysis  of pancreatic  HSP60  
and  HSP72  expression.  Representative  Western  
blots  of  protein  (20  pg/lane)  extracted  from  the  
pancreata  of  untreated  rats (0 ) ,  and  rats  treated  (B)  
or  not  treated ( 0 B )  with  the  HSP  co-inducer  BRX-
220  (20  mg/kg)  during  CCK-induced  acute  
pancreatitis  are  shown  (see  the  detailed  description  
in  the  2.5.3  Experimental  protocol).  Supramaximal  
doses  of CCK  (B, 0 B )  reduce  the pancreatic  levels  
of  HSP60  and  HSP72  vs  animals  not  receiving  any  
BRX-220  and  CCK  (0) .  Rats  treated  with  BRX-
220  (B)  are  shown  to  have  higher  levels  of  HSP60  
and  HSP72  vs  rats  receiving  physiological  saline  
( 0 B )  during CCK-induced  acute  pancreatitis.  
Pw/bw, serum  amylase  activity  (Fig.  11).  In  group  CC,  pw/bw  (3.24 ± 0 . 1 3  mg/g)  
and  the  serum  amylase  activity  (9,690  ±  1,114  U/l)  were  significantly  decreased  vs  group  
0 C C  (3.69 ±0.15  mg/g  and  23,400  ±  4,625  U/l,  respectively).  In  group  HC,  pw/bw  (4.00  ±  
0.15  mg/g)  and  the  serum  amylase  activity  (23,330  ±  1,412  U/l)  were  significantly  decreased  
vs  group 0 H C  (4.65  ±  0.29  mg/g  and  30,063  ±  1,676  U/l,  respectively).  In  group  CT,  pw/bw  
(4.20  ±  0.28  mg/g)  and  the  serum  amylase  activity  (6,523  ±  536  U/l)  were  significantly  
decreased  vs group 0 C T  (5.84 ± 0.76 mg/g  and  10,360 ± 720 U/l,  respectively).  
Serum  cytokine  levels  (Fig.  12).  In  
group  HC,  the  serum  levels  of  TNF-a  
(11.3  ±  5.7  U/ml),  IL-1  (6.6  ±  3.0  
pg/ml)  and  IL-6  (18.8  ±  10.4  pg/ml)  
were  all  significantly  decreased  vs  the  
corresponding  values  in  group  0 H C  
(50.0  ±  3.0  U/ml,  38.9  ±  4.6  pg/ml,  
and  50.0  ±  1.0 pg/ml,  respectively).  In  
group  CC,  the  serum  TNF-a  (76.0  ±  
8.0  U/ml)  level  was  significantly  
elevated  vs  group 0 C C  (not  detected).  
In  group  CT,  the  serum  level  of  IL-6  
(91.7  ±  5.9  pg/ml)  was  significantly  
decreased  vs  group  0 C T  (175.0  ±  
Fig.  11.  A.  Pancreatic  weight/body  weight  ratio  (pw/bw)  
and  B.  serum amylase  levels  in the  rats  with  CCK-,  TC-  and  19.8  pg/ml).  In  group  HA,  the  serum  
Arg-induced  acute  pancreatitis.  Groups  were  treated  as  tx tu '  
indicated  in the text  (2.5.1.). Means  ±  SEM  for 6 animals  are  l e v e l s  o f  TNF-a  (7.0  ±  4.7  U / m l ) ,  
shown.  *,  Significant  difference (p  <  0.05)  vs  the  respective  
control  group.  
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IL-1  (not  detected),  and  IL-6  (16.0  ±  4.8  pg/ml)  were  all  significantly  decreased  vs  the  
corresponding  values  in  group 0 H A  (80.0  ±  14.6  U/ml,  37.6  ±  8.5  pg/ml  and  170.0  ±  14.6  
pg/ml,  respectively).  In group  CA,  the  serum TNF-a  (15.0  ±  10.0 U/ml)  and  IL-1  (18.9  ±  0.7  
pg/ml)  levels  were  significantly  decreased  vs  group 0 C A  (76.7  ±  1.2  U/ml  and  88.4  ±  33.2  
pg/ml,  respectively).  
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Fig.  12.  Serum  A.  TNF-a,  B.  IL-1  and  C.  IL-6  
levels  in  the  rats  with  CCK-,  TC-  and  Arg-induced  
acute  pancreatitis.  Groups  were  treated  as  indicated  
in  the  text  (2.5.1.).  Means  ±  SEM  for  6  animals  are  
shown.  *,  Significant  difference  (p  <  0.05)  vs  the  
respective  control  group.  
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Pancreatic  contents  of  protein,  DNA,  amylase,  trypsinogen  and  lipase  (Fig.  13).  In  
group  CC,  the  pancreatic  contents  of  protein  (56.3  ±  7.6 mg/pancreas)  and  DNA  (2.18  ±  0.28  
mg/pancreas)  were  significantly  decreased  vs  group 0 C C  (84.0 ±5 .16  mg/pancreas  and  3.02  
±  0.21  mg/pancreas,  respectively).  The  pancreatic  contents  of amylase,  lipase  and  trypsinogen  
were  significantly  decreased  in  group  CC  (1,008 ±216  IU/pancreas,  169.1  ±  8.4  IU/pancreas  
and  3.16  ±  0.60  IU/pancreas,  respectively)  vs  group 0 C C  (3,612  ±  1,007  IU/pancreas,  198.0  
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±15 .1  IU/pancreas  and  5.52  ±  0.67  IU/pancreas,  respectively).  The  pancreatic  contents  of  
protein,  amylase,  lipase  and  trypsinogen  were  significantly  decreased  in  group  HC  (98.9  ±  4.2  
mg/pancreas,  6.464  ± 5 1 9  IU/pancreas,  209.6  ±  26.3  IU/pancreas  and  5.09  ±  0.50  
IU/pancreas,  respectively)  vs  group  0 H C  (124.9  ±  16.3  mg/pancreas,  10,244  ±  1,470  
IU/pancreas,  343.3  ±  30.4  IU/pancreas  and  7.08  ±  1.30  IU/pancreas,  respectively).  In  group  
HA,  the  pancreatic  contents  of  protein  (76.5  ±  13.3  mg/pancreas)  was  significantly  decreased  
vs  group  0 H A  (113.0  ±  10.8  mg/pancreas).  The  pancreatic  contents  of  amylase  and  
trypsinogen  were  significantly elevated  in group HA (5,568  ±  1,719 IU/pancreas  and  6.7  ±  1.0  
IU/pancreas,  respectively)  vs  group  0 H A  (2,514  ±  421  IU/pancreas  and  3.6  ±  1.2  
IU/pancreas). 
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Fig.  13.  Pancreatic  contents  of  A.  protein,  B.  DNA,  C.  trypsinogen,  and  D.  amylase  in the  rats  with  CCK-,  TC-
and  Arg-induced  acute  pancreatitis.  Groups  were  treated  as  indicated  in  the  text  (2.5.1.).  Data  represent  means  ±  
SEM  for 6 animals.  *, Significant  difference (p  < 0.05)  vs the respective  control  group.  
22 
Light microscopy.  In group CC, the total pancreatic  damage (3.71  ± 0.53  points)  was  
significantly  decreased vs  group 0CC  (5.07  ±  0.45  points).  In group CT,  the total  pancreatic  
damage  (8.01  ±  0.29  points)  was  significantly  elevated  vs  group 0CT  (6.02  ±  0.83  points).  
The point values for each of the scored parameters  are shown in Table 2. 
Table  2. Effects of cold- and hot-water  immersion  pretreatment  on the histologic parameters  in cholecystokinin-
octapeptide-,  sodium taurocholate-,  and L-arginine-induced  acute pancreatitis.  
Group  oHC  Group  HC  Group  ioCC  Group  CC  
Interstitial  edema  1.17=1=0.12 0.93*0.16 129*0.15 1.24.1,021 
Leukocyte  infiltration  0.78J-0.15 0.30*0.06* (126*0.02 0.29*0.03 
Leukocyte  adherence  0.4010.16 0.35*0.05 0.49*0.05 0.52*0.06 
Vacuolization 1.4 3,10.17 0.95*0.11* 1.15*0.12 0.33*0.05* 
Nccrosis  (0-4)  0.3510.18 0.14*0.12 0.31*020 0.20*0.13 
Basophilic  lamellation  1.83J.0.20 1.93*0.29 1.51X0.08 0.90*0.05* 
Apoptosis 1.03*0.13 1.26*0.17 0.38*0.04 0.43*0,05 
Total  damage  6.63*0.82 5.85*0.87 5.07*0.45 3.7H0.53* 
Group  e 1 IT Croup  HT  Group  «CT  Group  CT  
Interstitial  edema  2.45*0.22 2.47*0.13 2.27*020 1.80*0.15* 
Lcukocyte  infiltration  2.0740.21 1.90*0.17 1.09*0.39 1.05*0.22 
Lcukocyte  adherence  0.73*0.13 0.77*0.11 0.57*021 0.42*0.17 
'Hemorrhage 0.32*0.14 0.35*0.12 0.09*0.08 0.42*0.13* 
Necrosis  (0-4)  0.50*0.21 0.50*0.18 0.29*0.16 0.60*0.17 
Basophilic  lamellation  0.6210.24 0.43*0.08 0.54*0,08 1.0610.20* 
Hyperemia 1.27*0.22 1.33*0.25 1.04  X0.15  1.98*0.05* 
Total  damage  7.87*0.84 8.15X0.71 6.02*0.82 7.71*0.29* 
Group  oil A Group  HA  Group  eCA  Group  CA  
Interstitial  edema  1.23*0.09 1.17*0.45 1.00*0.17 0.86*0.06 
Lcukocyte  infiltration  1.30*022 1.01*0.42 0.46*0.15 (1.82*0.09* 
Lcukocyte  adherence  0.80*0.26 0.45*0.18 0.74*0.16 0.63*0.18 
Vacuolization 0.52*0.08 0.30*0.16 0.52*0.32 0.38*0.17 
Nccrosis  (0—4)  1.12*0.25 0.74*0.40 0.42*026 0.57*021 
Basophilic  lamellation  0.65*0.0 5 0.32*0.15 0.84*0.20 0.39*0.15 
Apoptosis 0.64*0.10 0.34*0.19 0.45  40.07  1.05*0.41 
Total  damage  6.36*0.76 4.33*126 4.43*1.01 4.70*1.05 
Note:  Groups  were  treated  as  described  in  the  test.  Data  are  means  —  Sl£  for  six  animals.  »Significant  difference  
l/i  <  0.05)  versus  the  respective  control  group.  
Electron  microscopy.  An electron microscopic  study was performed to evaluate the 
cause of the basophilic  lamellation of the cytoplasm of the acinar cells.  Figure  14 shows that 
this was due to tightly packed rough endoplasmic  reticulum.  
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Fig.  14. Transmission  electron  micrograph  of the  pancreas  from  a rat  2  hours after the  last  of three  s.c.  injections  
of  75  pg/kg  body  weight  of  CCK  (Group  HC).  Acinar  cells  exhibit  tightly  packed  rough  endoplasmic  reticulum  
corresponding  to  the areas  of basophilic  lamellation  of the cytoplasm  of the cells (original  magnification  4600x).  
3.5.  The  effect  of  sodium  arsenite  pretreatment  on  CCK-induced  acute  
pancreatitis  (IV).  
The  administration  of  3  x  75  pig/kg  b.w.  CCK  induced  the  typical  laboratory  and  
morphological  changes  of experimental  acute pancreatitis  (3).  
The  pw/bw  ratio  and  serum  amylase  activity  (Fig.  15).  In  group  HC,  the  pw/bw  
(4.05  ±  0.27  mg/g)  and  the  serum  amylase  activity  (12,428  ±  1,134  U/l)  were  significantly  
decreased  vs  group 0 H C  (4.89  ±  0.28  mg/g  and  18,251  ±  1993  U/l,  respectively).  In  group  
AC-2,  the  serum  amylase  activity  (10,515  ±  1,539  U/l)  was  significantly  decreased  vs  group  
SC-2  (16,150  ±  1,633  U/l).  Otherwise,  SA  pretreatment  had  no  effect  on  pw/bw  and  serum  
amylase  activity.  
Serum  cytokine  levels  (Fig.  16).  In  group  HC,  the  serum  levels  of  IL-1  (5.3  ±  2.1  
pg/ml)  and  IL-6  (28.0  ±  8.6  pg/ml)  were  all  significantly  decreased  vs  the  corresponding  
values  in  group 0 H C  (34.8  ±  7.2  pg/ml,  and  60.0  ±  10.0  pg/ml,  respectively).  No  significant  
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changes  were  observed  in  the  serum  IL-1  and  IL-6  levels  in  the  SA-pretreated  groups  vs  the  
respective  controls.  
G r o u p s  G r o u p s  
Fig.  15.  A.  The  pancreatic  weight/body  weight  ratio  (pw/bw)  and  B.  serum  amylase  levels  in  groups  0 H C ,  HC,  
SC-2,  AC-2,  SC-6  and  AC-6.  The  groups  were  treated  as  indicated  in  Figs.  1/B  and  4.  Means  ±  SEM  for  6  
animals  are  shown.-j^  Significant  difference (p  < 0.05)  vs the  respective  control  group.  
G r o u p s  G r o u p s  
Fig.  16.  Serum  A.  IL-1  and  B.  IL-6  levels  in  groups  0 H C ,  HC,  SC-2,  AC-2,  SC-6  and  AC-6.  Groups  were  
treated  as  indicated  in  Figs.  1/B  and  4.  Means  ±  SEM  for  6  animals  are  shown.  Significant  difference  (p  <  
0.05)  vs the  respective  control  group.  
Pancreatic  contents  of  DNA,  protein,  amylase,  tripsinogen  and  lipase  (Fig.  17).  
The  pancreatic  contents  of  protein  were  significantly  decreased  in  group  HC  (85  ±  6  
mg/pancreas)  vs  group  0 H C  (115  ±  11  mg/pancreas).  The  pancreatic  contents  of  amylase,  
trypsinogen  and  lipase  in  group  HC  (6,280  ± 690  IU/pancreas,  7.98  ± 0.91  IU/pancreas,  310  ±  
29  IU/pancreas,  respectively)  were  significantly  elevated  vs  group  0 H C  (4,120  ±  450  
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IU/pancreas,  5.30  ±  0.65  IU/pancreas,  220  ±  24  IU/pancreas,  respectively).  In  group  AC-6,  
the  pancreatic  contents  of  protein  (95  ±  13  mg/pancreas),  amylase  (4,692  ±  1,008  
IU/pancreas)  and  trypsinogen  (7.6  ±  1.2  IU/pancreas)  were  significantly  decreased  vs  group  
SC-6  (126  ±  7  mg/pancreas,  8,369  ±  2,020  IU/pancreas  and  11.1  ±  0.9  IU/pancreas,  
respectively). 
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Fig.  17.  Pancreatic  contents  of  A.  protein,  B.  DNA,  C.  trypsinogen,  D. amylase,  and  E.  lipase  in  groups  0HC,  
HC,  SC-2,  AC-2,  SC-6  and  AC-6.  Groups  were  treated  as  indicated  in  Figs.  1/B  and  4.  Data  are  means  ±  SEM  
for 6 animals.TV  Significant difference (p  < 0.05)  vs the  respective  control  group.  
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Lung  myeloperoxidase  activity  
(Fig.  18).  In  group  HC,  the  lung  
myeloperoxidase  activity  (25.2  ±  4.7  U/mg  
protein/min)  was  significantly decreased  vs  
group  0 H C  (45.1  ±  9.6  U/mg  
protein/min). No  significant change  in  lung  
myeloperoxidase  activity  was  detected  
between  the  SA-treated  and  the  control  
groups. 
Light  microscopy.  No  significant  
alteration  was  observed  between  the  
groups  as  concerns  the  total  pancreatic  
damage.  The  point  values  for  each  of  the  
scored parameters  are shown  in Table  3.  
Table  3.  Effects  of  sodium  arsenite  and  hot-water  immersion  pretreatment  on  the  histologic  parameters  in  
cholecystokinin-octapeptide-induced  acute  pancreatitis.  Groups  were  treated  as  indicated  in  Figs.  1/B  and  4.  
Data  are means  ±  SEM  for 6 animals.  *, significant difference (p  < 0.05)  vs the  respective  control  group.  
Group  SC-2  Group  AC-2  Group  0HC  Group  HC  Group  SC-6  Group  AC-6  
Interstitial  edema  1.40 i  0.15  1.08 ±0.16 1.20 ±  0.13  1.02 ±  0.09  1.13 2 0.16 1.19 2 0.24 
Leukocyte  inflltr.  0.56  +  0.11  0.48 ±  0.09  0.70  ±0.16  0.22  ±  0.05*  0.68 2  0.38 0.3710.20 
Hyperemia 0.27 ±  0.07  0.38 ±0.10 0,39 ±0.11 0.45  ±  0.08  0.70 2 0.16 0.60 ±  0.13  
Vacuolization 0.88 ±  0.14  0.92 ±0.12 1.11 ± 0.19 0.70  ±  0.08*  0.32 2 0.14 0.35 ±  0.07  
Necrosis  (0-4)  0.4210.07 0.48 ±  0.08  0.39 r  O.OS  0.25 ±  0.05  0.45 2  0.06 0.42  ±  0.09  
Apoptosis 0.73 ± 0.15 0.98+0.19 0.90 2 0.15 0.95  ±0.16  0.34  ±  0.05  0.24  ±  0.04  
Basoph.  lam.  0,9610.19 1.35  ±0.12  1.38 ±0.18 1.32 ±  0.13  0.30 ±  0.12  0.73  ±  0.27  
Total  damage  4.90  ±  0.56  5.3410.38 6.03 i  0.63  5.45 ±  0.58  3.93 ±  0.70  3 90  2  0.78  
3.6. The effect of  BRX-220  on CCK-induced  acute  pancreatitis  (V).  
Pancreatic  weight/body  weight  ratio  (pw/bw),  serum  amylase  activity  and  plasma  
TAP  concentration.  In  group  B,  pw/bw  (2.16  ±  0.05  mg/g)  and  the  serum  amylase  activity  
(1447  ±  108  IU/1) were  not  significantly different vs  group 0 B  (1.89  ± 0.15 mg/g  and  1317 ± 
142  IU/1,  respectively)  (Fig.  19/A,B).  In  group  B,  the  plasma  TAP  concentration  (20  ±  5  
nM/ml) was significantly decreased  vs group 0 B  (39  ± 6 nM/ml)  (Fig.  19/C).  
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Fig.  18.  Lung  myeloperoxidase  activities  in  groups  
0 H C ,  HC,  SC-2,  AC-2,  SC-6  and  AC-6.  Groups  
were  treated  as  indicated  in  Figs.  1/B  and  4.  Data  are  
means  ±  SEM  for  6  animals.  Significant  
difference (p  < 0.05)  vs the  respective  control  group.  
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Pancreatic  contents  of  DNA,  protein,  amylase,  trypsinogen  and  lipase.  In  group  B,  
the  pancreatic  contents  of protein  (38.0  ±  4.1  mg/pancreas),  amylase  (932  ±  138  IU/pancreas)  
and  trypsinogen  (2.99 ±0.16  IU/pancreas)  were  significantly  increased  vs  group 0 B  (21.0  ±  
1.5 mg/pancreas,  482  ±  109 IU/pancreas,  and  1.88 ± 0.23  IU/pancreas,  respectively)  (Fig.  20).  
No  significant changes were  detected  in the pancreatic  contents  of DNA  and  lipase  in group  B  
(1.69  ±  0.25  mg/pancreas,  8.45  ±  9.45  IU/pancreas,  respectively)  vs  group 0 B  (1.47  ±  0.31  
mg/pancreas,  8.98 ± 6.44  IU/pancreas).  
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Fig.  19.  A.  Pancreatic  weight/body  weight  
ratio  (pw/bw),  B.  serum  amylase  and  C.  
plasma  trypsinogen  activation  peptide  (TAP)  
levels  in  groups  0 B  and  B.  Groups  were  
treated  as  indicated  in  the  Experimental  
protocol  (2.5.3.).  Means  ±  SEM  for  6  animals  
are  shown.  Significant  difference  (p  <  
0.05)  vs the  control  group.  
Pancreatic  lipid  peroxidation,  protein  carbonyl  and  reduced  glutathione  levels,  
and  the  activities  of  superoxide  dismutase,  catalase  and  glutathione  peroxidase.  In  group  
B,  the  pancreatic  MDA  level  and  protein  carbonyl  content  were  significantly  decreased  (0.19  
±  0.01  nM/mg  protein,  8.36  ±  0.49  nM/mg  protein,  respectively)  vs  group 0 B  (0.35  ±  0.04  
nM/mg  protein,  6.75  ± 0.38)  (Fig.  21/A,  B).  The  activity  of  pancreatic  GPx  was  significantly  
increased  in  group  B  (2.07  ± 0 . 1 7  U/mg  protein  x  10"3)  vs  group  0 B  (not  detected)  (Fig.  
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21/C).  In  group  B,  the  activity  of  pancreatic  Cu/Zn-SOD  (4.90  ±  0.59  U/mg  protein)  was  
significantly  decreased  vs  group 0 B  (7.13  ±  0.56  U/mg  protein)  (Fig  21/D).  No  significant  
alterations  were  observed  in the  pancreatic  GSH  level  (1.00  ±  0.13  pM/mg  protein  x  10"),  or  
the  activities  of  Mn-SOD  (not  detected)  and  catalase  (0.41  ±  0.06  U/mg  protein  x  10"3)  in  
group  B  vs  group 0 B  (0.86  ±  0.06  pM/mg  protein  x  10'2,  not  detected,  0.54  ±  0.07  U/mg  
protein  x  10"  ,  respectively).  
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Fig.  20.  Pancreatic  contents  of  A.  protein,  
B.  amylase,  and  C.  trypsinogen  in  groups  
0 B  and  B.  Groups  were  treated  as  
indicated  in  the  Experimental  protocol  
(2.5.3.).  Data  are  means  ±  SEM  for  6  
animals.  ^  Significant  difference  (p  <  
0.05)  vs the  control  group.  
Light  microscopy.  The  administration  of  repeated  injections  of  CCK  resulted  in  the  
typical  picture  of  an  acute  interstitial  pancreatitis  (interstitial  edema,  vacuolization,  leukocyte  
infiltration,  and  acinar  cell  injury  of  the  pancreas).  In  group  B,  the  total  morphological  
damage  (4.75  ± 0 . 1 7  points)  was  significantly  decreased  vs  group 0 B  (6.17  ±  0.53  points)  
(Fig.  22).  The  point  values for each  of the  scored  parameters  are  shown  in Table  4.  BRX-220  
treatment  significantly ameliorated  the pancreatic  leukocyte  infiltration and  adherence  and  the  
vacuolization,  necrosis  and apoptosis  of the acinar  cells.  
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Fig.  21.  Pancreatic  A. malondialdehyde  levels,  B. protein  carbonyl  content  and  C.  glutathione  peroxidase,  and  D.  
Cu/Zn-superoxide  dismutase  activities  in  groups  0 B  and  B.  Groups  were  treated  as  indicated  in  the  
Experimental  protocol  (2.5.3.).  Means  ± SEM  for  6  animals  are shown .^S ign i f i can t  difference (p  < 0.05)  vs  the  
control  group. N.D.:  not  detected.  
G r o u p  0 1 1  Group  B  
IS  e d e m a  /  1.44 ± 0 . 2 0 1.46 + 0.17 
Leukocyte  infiltration  2 .29 + 0 . 2 0 1.83 ± 0 .12* 
Leukocyte  adherence  0 .17 0 . 0 3 0 .06 0 .01* 
Vacuol izat ion 0 .44 0 . 0 7 0 .10 -t- 0 .01* 
Necrosis  ( 0 - 4 )  0 .29 0 . 0 3 0 .19 0 . 0 3 * 
Apoptos is 0 .79 0 . 0 9 0 .42 -r 0 .03* 
Basophi l ic  lamdia t ior i  0 .15 -4- 0 . 0 3 0 . 1 3 -f- 0.01 
I lyperemia 0 .60 + 0.08 0 .56 -r- 0 .05 
Total  d a m a g e  6 .17 0 .53 4 .75 ± 0.17* 
Table  4.  Effects  of  BRX-
220  on  the  histologic  
parameters  in  chole-
cystokinin-octapeptide-
induced  acute  pancreatitis.  
Groups  were  treated  as  
indicated  in  the  Experi-
mental  protocol  (2.5.3.).  
Data  are means  ± SEM  for  6  
animals.  *,  Significant diffe-
rence  (p  <  0.05)  vs  the  
control  group.  
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Fig.  22.  Heat  shock  protein  co-inducer  BRX-220  protects  against  CCK-induced  acute  pancreatitis.  The  Figure  
shows  the  histological  pictures  of  pancreata  from  rats  either  A.  not  treated  (Group 0 B )  or  B.  treated  with  BRX-
220  (Group  B)  12  hours  after  the  last  injection  of  75  pg/kg  body  weight  of  CCK.  Treatment  with  BRX-220  
(Group  B)  significantly  reduced  the  CCK-induced  morphological  alterations  (intrapancreatic  inflammation,  
vacuolization,  necrosis  and  apoptosis  of acinar  cells)  (hematoxylin  and  eosin,  original  magnification  200x).  
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4. DISCUSSION 
The members of the  major cytoprotective HSPs  are constitutively  expressed  or can be 
induced  in  the  pancreas  (14).  Cells  subjected  to  a  mild,  sublethal  stress  event  sufficient  to  
increase  the  levels  of  HSPs  are  able  to  survive  a  subsequent  more  serious  stress  event  (9).  
HSP preinduction is known to protect the pancreas  against cerulein-  and dibutylin  dichloride-
induced  pancreatitis  in  rats  or  against  choline-deficient  ethionine-supplemented  diet  model  
pancreatitis in mice (15-23).  Our first set of experiments were designed to compare the effects 
of  CWI  and  HWI  pretreatment  and  the  potential  effects  of  HSP  preinduction  (HSP60  and  
HSP72)  on three different acute pancreatitis models  (I-III).  Pancreatitis  was  induced  near the 
peak  of  pancreatic  HSP  expression  by  administering  high  doses  of  CCK  or  Arg,  or  by  the  
injection of TC into the common biliopancreatic  duct.  
In agreement  with  the findings of  Otaka et  al.  (20),  our results  demonstrate  that  CWI 
specifically induces HSP60, while  HWI increases the expression of HSP72  in rats.  We found 
that  the  levels  of  HSP60  remained  significantly  elevated  for  9  h  after  CWI.  This  is  in  
accordance  with  what  was  observed  by  Lee  et  al.  (19).  The  quantity  of  HSP72  was  
significantly increased  at  3  h after HWI,  and remained  elevated  until  12  h.  Otaka  et  al.  (20)  
reported  the  HSP72  expression  peak  at  6  h,  which  could  be  due  to  the  differences  in  the  
experimental  protocols.  
Although  HSPs  have  been  implicated  as  mediators  of  pancreatic  protection,  these  
proteins were mostly  induced by thermal methods (16-23).  Water immersion stress results in a 
number of stress-induced responses, like metabolic alterations,  the inhibition of nuclear  factor  
kappa  B  (NF-icB)-binding  activity  (17)  and  the  synthesis  of  a  variety  of  proteins  besides  
HSP60  and HSP72, which may have protective roles in the prevention of a subsequent  stress.  
For example,  the antioxidant  enzymes  catalase  and manganese  SOD  can also  take part in the 
protective effect (24,25).  Therefore, (besides HSPs) we also examined the levels of pancreatic 
antioxidants after the water immersion stress. However, we could not detect elevated levels  of  
/ 
pancreatic  antioxidants.  
Previously  reported  data concerning the protective role of  different HSPs  (particularly  
HSP60  and HSP72)  against  cerulein-induced  pancreatitis  are  conflicting.  Wagner  et  al.  (21)  
and  Frossard  et  al.  (17,18)  demonstrated  that  the  expression  of  HSP70,  induced  by  
hyperthermia,  correlated  best  with the time course  and degree  of protection  against  cerulein-
induced pancreatitis.  Convincing  evidence of the protective  effects of  pancreatic  HSP72  was  
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provided  by  Bhagat  et  al.  just  recently  (16).  They  have  shown  that  hyperthermia  induced  
pancreatic HSP70 expression,  prevented  intrapancreatic  trypsinogen activation,  and protected 
against  pancreatitis.  The  administration  of  HSP70  antisense  oligonucleotides  reduced  the  
thermal  stress-induced  HSP70  expression,  restored  the  ability  of  supramaximal  cerulein  
stimulation to cause intrapancreatic trypsinogen  activation,  and abolished the protective effect 
of  prior  thermal  stress.  Moreover,  in  non-thermally  stressed  animals,  pretreatment  with  
HSP70  antisense  oligonucleotides  before  the  induction  of  pancreatitis  exacerbated  all  the  
parameters  associated  with  pancreatitis.  In  contrast  with  these  data,  Otaka  et  al.  (20)  found  
that  the  specific  preinduction  of  HSP72  by  hot-water  immersion  (42  °C,  20  min)  had  no  
preventive  effect  against  cerulein-induced  pancreatitis,  whereas  HSP60  (induced  by  CWI)  
did.  The beneficial  effect of  CWI pretreatment  and possibly  HSP60  against  cerulein-induced  
pancreatitis  was  also  reported  by  Lee  et  al.  (19).  In  fact,  our  studies  confirm  that  HSP60  
might indeed play a role in the protection.  In the experiments of  Otaka et al  (20)  and Wagner 
et  al.  (21),  heating  the  animals  did  not  or just  slightly  increased  the  expression  of  HSP60.  
Therefore,  the  possible  protective  effect of  HSP60  could  not  be  excluded  by  these  studies,  
while  the  role  of  HSP72  remained  questionable.  We  considered  that  the  lack  of  protection  
against  CCK-induced  pancreatitis  in the  case  of  HWI  pretreatment  by  Otaka  et  al.  (20)  was  
probably due to the inadequate duration of restraint stress and/or the increase of the core body 
temperature of the  rats immersed in the hot-water  bath.  Therefore, the HSP72 expression  did  
not reach a high enough level  to protect the pancreas against acute pancreatitis.  In the present 
study, the duration of the HWI pretreatment was longer than that applied by  Otaka et al.  (20),  
because  we  hypothesised  that  our  experimental  setup  would  result  in  a  higher  core  body  
temperature  and consequently  a higher HSP72  synthesis.  Our results suggest  that both HSP60 
and  HSP72  may  play  an  important  part  in  protecting  the  pancreas  against  CCK-induced  
pancreatic  damage.  However,  we  must  note  that  HWI  pretreatment  and  possibly  even  the  
higher  level  of  HSP72  were  not  sufficient  to  significantly  decrease  the  severity  of  the  
morphological  picture  of  the  disease.  This  might  be  due  to  the  different  type  of  
preconditioning  used  in  our  experiments,  or  the  inadequate  amount  of  HSP72  to  produce  
morphological  protection.  In vitro  studies have  shown that  culture  stress-induced  HSP72  can  
prevent  the  intra-acinar  cell  activation of  trypsinogen  caused  by  cerulein  in freshly prepared 
rat pancreas segments (15).  Frossard et al.  (18) have found that both thermal  and non-thermal 
((3-adrenergic  stimulation  by  isoproterenol)  protected  against  cerulein-induced  pancreatitis.  
The  upregulated  HSP72  expression  was  localised  to  the  cytoplasmic  acinar  cell  vacuoles  
which  are believed to be the site of trypsinogen activation. However,  Kruger et al.  found that, 
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although  hyperthermia  can  directly  abolish  the  premature  and  intracellular  activation  of  
digestive  zymogens  in  cerulein-induced  pancreatitis,  this  is  independent  of  the  synthesis  of  
pancreatic  HSPs  (47).  Therefore, it is possible  that the protective  effect of  heating  or cooling 
is due not merely to increased HSP synthesis,  but also to nonspecific effects such as inhibition 
ofNF-KB binding activity (17)  or hormonal release  (48,49).  
We  found  that  CWI  pretreatment  and  possibly  HSP60  ameliorated  the  pancreatic  
edema  and the  serum amylase  level  in TC-induced  pancreatitis  6 h after the  induction of  the  
disease.  Unexpectedly,  CWI  preconditioning  significantly  worsened  the  morphological  
picture of the pancreatitis.  This might be  due to the microcirculatory  changes caused  by  CWI 
(50),  which is  supported by the fact that the animals  in  group CT exhibited a greater vascular 
involvement  (hyperemia  and  hemorrhage)  than  that  in  the  control.  It  is  also  plausible  that,  
besides  or  instead  of  HSP60,  hypothermia  itself  has  a protective  effect  on  the  pancreas.  To  
investigate this possibility,  in a separate set of experiments we raised the body temperature of 
the rodents to 37 °C over a 2.5-h period after the CWI (results not demonstrated in the paper), 
in  the  belief  that  this  would  not  affect the  quantity  of  HSP60.  Unfortunately,  the  reheating  
process  decreased  the  level  of  this  protein  to  the  basal  value.  Nevertheless,  the  reheating  
abolished the protective  effect seen in pw/bw  and the  serum amylase  level,  but  improved the 
morphological  parameters  (histology)  to  an  insignificant  difference  as  compared  to  the  
control.  HWI pretreatment  did not have  any effect on the  measured  parameters of this  severe  
acute necrohemorrhagic  pancreatitis.  
It  is  well  known  that  the  proinflammatory  cytokine  levels  increase  during  
experimental  acute pancreatitis (3,51,52).  We demonstrated  decreases  in these cytokine levels  
after HWI pretreatment in the animals with Arg-induced pancreatitis.  Interestingly,  even CWI 
pretreatment decreased the serum IL-1  and TNF-a levels in this acute necrotizing pancreatitis. 
In this case, we can speculate that the decreased levels of cytokines  are due to the reduction of 
cytokine  production  in  the  extrapancreatic  origins,  since  the  severity  of  Arg-induced  
pancreatitis  was  not  influenced  by  CWI  pretreatment.  CWI  pretreatment  did  not  effect  the  
serum IL-6  level  in this  acute pancreatitis  model,  which closely  reflects the  severity  of  acute  
pancreatitis  (53).  
The  differential  protective  effects  of  HSPs  were  called  to  our  attention  by  several  
investigators.  Cumming  et  al.  (54)  reported  that  the  overexpression  of  HSP70  protected  the  
cardiac cells  against  subsequent exposure to either thermal  or ischemic  stress,  overexpression  
of  HSP90  produced  a  protective  effect  only  against  thermal  stress,  while  HSP60  had  no  
protective  effect.  Likely,  our  experiments  suggest  that  HSP60  and  HSP72  may  both  have  
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differential  effects  in  protecting  the  pancreas  against  detrimental  stimuli.  Their  protective  
actions are not ubiquitous. 
To  bypass  the  confounding effects of  the  changes  in the  body  temperature,  rats were 
administered  SA  (IV)  and BRX-220  (V)  before the  induction  of  edematous  pancreatitis.  SA  
itself  does  not  influence  the  body  temperature  of  the  animals  (55).  Intravenous  (i.v.)  
administration of SA is known to increase the level of HSP72 in the kidney,  heart and liver of 
rabbits (56).  Our results are in accordance with those of Ribeiro  et al.  (55), who  demonstrated  
that the  injection of SA specifically  induces HSP72  in the lungs of  rats.  Ribeiro  et  al.  used a 
dose of 6 mg/kg i.v. to induce HSP72 (55).  In their hands, a dose of  10 mg/kg produced signs  
of  acute  poisoning  in  the  animals  (this  appeared  at  a  higher  dose  in  our  experiments).  
However,  the  route  of  SA  administration  was  different.  Moreover,  our  study  revealed  that  
HSP72 was also induced in the pancreas of the animals. The levels of HSP60 were  unchanged 
after HWI or SA treatment in both of the examined organs. Wijeweera  et  al.  also showed that 
SA treatment does not influence HSP60 expression (whereas the level  of HSP72 increases)  in  
precision-cut  rat lung slices (57).  
Similarly  to  our  earlier  experiments,  acute  pancreatitis  was  induced  near  the  peak  of  
pancreatic  HSP  expression  (9  h after the  SA  injection)  by  administering  high  doses  of  CCK  
s.c.  While  HWI  pretreatment  ameliorated  most  of  the  examined  laboratory  and  some  
morphological  parameters  of  CCK-induced  pancreatitis,  we  did  not  find  such  an effect after 
SA pretreatment despite the similar levels of pancreatic HSP72 synthesis achieved  after either 
thermal  stress  or SA treatment.  Morover,  the pancreatic enzyme  contents were  more  depleted  
in  one  of  the  SA-pretreated  groups  (AC-6),  which  indicates  a more  severe  pancreatitis.  The  
extent  of  lung  injury  was  assessed  via  the  myeloperoxidase  activity.  HWI  pretreatment  
decreased  lung  injury,  whereas we  did not see  such  an effect after SA  treatment,  despite  the 
induction of HSP72. 
Unfortunately,  the  study  with  SA  does  not  confirm that  increased  pancreatic  HSP60  
synthesis  can play  a role  in the  protection  against  secretagogue-induced  pancreatitis,  since  it  
was not influenced by  HWI  or SA  injection.  Although a simple  upregulation of HSP72  does  
not seem to  be  sufficient for protection,  our results  do not completely  rule  out the  protective  
effect of HSP72  in CCK-induced  pancreatitis  after hyperthermia,  since the  elevation of body 
temperature could result in conformational  changes  and posttranslational  modifications of the 
HSPs which could account  for the protective effect (58).  It is also possible  that  SA  produced  
some  toxic  side-effect  on  the  animals  which  prevented  the  beneficial  properties  of  HSP72.  
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Taken together,  the possible  protective effect of HSP60  in CCK-induced  acute pancreatitis  is  
not excluded by our experiments, while the role of HSP72 remains questionable.  
Pancreatic  HSP  preinduction  by  thermal  or  non-thermal  methods  before  the  onset  of  
acute pancreatitis does not mimic the clinical reality.  Study No.  V was designed to  investigate  
the potential  effects of  a non-toxic  HSP  co-inducer  (induction of  HSPs  during the  course  of  
the  disease)  drug-candidate,  BRX-220,  on  CCK-induced  acute  pancreatitis  in  rats.  BRX-220  
is  a  structural  relative  of  bimoclomol,  which  has  been  shown  to  have  a  wide  range  of  
beneficial properties  in experimental  models of ischemic  diseases  and diabetic  complications,  
particularly  retinopathy,  neuropathy  and  angiopathy  (59-61).  BRX-220  exerts  its  beneficial  
effects over a longer time period,  and we  therefore chose to administer the  drug and CCK for 
5 days. 
Repeated  supramaximal  doses  of  CCK  stimulation  for 5  days  are known  to  induce  a  
prolongation of the morphological  (decreased pw/bw,  intrapancreatic inflammation and acinar 
cell  injury) and biochemical  changes  (decreased pancreatic  protein, DNA,  and GSH  contents;  
decreased  pancreatic  amylase,  lipase,  trypsinogen,  and  free  radical  scavenger  enzyme  
activities;  increased  pancreatic  lipid  peroxidation  and  protein  oxidation;  increased  plasma  
TAP concentration) of CCK-induced acute  interstitial  pancreatits (62,63).  We have found that 
BRX-220  treatment  ameliorated  many  of  these  laboratory  (plasma  TAP  concentration;  
pancreatic  lipid peroxidation  and protein oxidation; pancreatic  GPx, trypsinogen  and amylase  
activity;  total  protein  content)  and  morphological  changes  (vacuolization,  necrosis  and  
apoptosis  of  acinar  cells,  and  intrapanreatic  inflammation).  Though  not  significantly,  there  
was  a  tendency  of  BRX-220  to  hinder  the  decrease  in  pw/bw  caused  by  the  5-day  CCK  
injections  (p  =  0.08).  We  believe  that  these  cytoprotective  effects  are  due  to  the  beneficial  
effects of HSPs. 
In addition to causing pancreatitis,  supramaximally  stimulating doses of cerulein act as 
stressors  and  have  been  shown  to  induce  expression  of  HSPs  in  the  pancreas  (16,26).  In  
accordance  with  Strowski  et  al.  (29),  we  have  shown  that  supramaximal  doses  of  CCK  
/ 
paradoxically  reducfc  the  levels  of  HSP60  and  HSP72.  However,  this  decrease  was  
ameliorated  by  the  administration  of  the  HSP  co-inducer  BRX-220.  This  non-toxic  
hydroxylamine  derivative  upregulated the  expression  of pancreatic  HSP60  and HSP72  about  
two- to three-fold.  Therefore, BRX-220  acted  against  the effect of  CCK-induced  pancreatitis  
to decrease  the  levels  of these  HSPs,  and clearly  increased  the protection  against  the  disease  
as  discussed  above.  Since  we  only  examined  the  quantities  of  the  most  widely  investigated  
HSP60  and  HSP72,  we  can't  exclude  that  other  HSPs  are  induced  and  contribute  to  the  
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protective  effects  of  BRX-220.  Absolutely  decisive  proof of  the  protective  effects of  HSPs  
against  secretagogue  pancreatitis would  require  studies  which either more  specifically  induce  
HSPs  (for  example  transgenic  animals)  or  interfere  with  the  expression  (for  example,  HSP  
knockout animals) or function of these proteins. 
Although HSPs have been implicated as mediators of pancreatic protection, the precise 
mechanism of their cytoprotective effects remains to be completely  elucidated.  Accumulating  
evidence suggests  that HSPs  are most likely to attenuate cellular damage by their chaperoning 
activities  (14),  by  increasing  the resistance  of  the cells  to  apoptosis  (12,64)  or necrosis  (10),  
by  decreasing  pro-inflammatory  cytokine  levels  (65),  by  their  antioxidant  effects  (66),  by  
preventing  the  pathologic  rise  in  intracellular  calcium  concentration  that  follows  
supramaximal  cerulein  stimulation  (15)  and/or  by  preventing  intracellular  trypsinogen  
activation (15).  Our findings support many of these possibilities. 
CWI  stress  is  known  to  increase  the  level  of  HSP60  (1-111,19,20).  Previous  
investigations  have  shown,  however,  that  injections  of  cerulein  combined  with  water-
immersion  stress  increase  the  severity  of  the  disease  (although  these  investigators  were  
dealing with the effects of stress  on pancreatitis,  and not HSPs)  (67).  An explanation for this 
in  respect  of  the  HSPs  was  offered  by  Otaka  et  al.,  who  proposed  that,  when  stress  was  
applied  after  cerulein  injection,  the  acinar  cells  had  already  been  damaged  by  cerulein  and  
HSP60  could  not  be  synthesized  in  the  cells  (21).  Furukawa  et  al.  claim  that  pancreatitis  is  
exacerbated  due  to  the  decreased  blood  flow  to  the  pancreas  and  microcirculatory  
disturbances  which  lead  to  the  activation  of  zymogen  proteases  in  the  pancreas  (68).  
Therefore,  the  above-mentioned  data  are  not  in  contradiction  with  ours,  since  CWI  was  
administered  as  a pretreatment  and BRX-220  has  no  such  side-effects.  Moreover,  this  calls  
attention to  the fact that the co-induction  of HSPs  should  be  achieved  only  by  a method that 
does not have harmful effects on the disease to be treated. Non-toxic HSP-inducer drugs could 
be one convenient way to approach this problem. 
In conclusion,  we  have  shown that HWI and SA  specifically  induces  the  synthesis  of  
pancreatic  HSP72,  while  CWI  specifically  elevates  the  level  of  pancreatic  HSP60.  We  
demonstrated  the  differential  protective  effects  of  water  immersion  pretreatment  on  three  
acute  pancreatitis  models.  Water  immersion  pretreatment  (and possibly  HSP60  and  HSP72)  
exerts  a  definite  protective  effect  in  mild  pancreatitis,  whereas  this  was  not  seen  in  more  
severe  acute  pancreatitis  models.  On  the  other  hand,  the  protective  effect  of  hyperthermia  
seems to be independent of the increased HSP72 synthesis since the non-thermal  induction of 
HSP72  by  SA  failed  to  reduce  the  severity  of  CCK-induced  acute  pancreatitis  and  
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pancreatitis-associated  lung  injury.  We have  found  that  repeated  injections  of  supramaximal  
doses of  CCK for 5  days paradoxically  decrease  the  levels  of  pancreatic  HSP60  and HSP72.  
This reduction was  ameliorated by the administration of  the non-toxic  HSP co-inducer,  BRX-
220.  We were  the  first to  demonstrate  that a non-toxic  HSP-inducer  compound  administered  
during  the  course  of  the  disease  can  protect  against  CCK-induced  pancreatitis.  These  
cytoprotective effects of the drug are most probably  due to the upregulated synthesis of HSPs. 
Our  findings  suggest  the  possible  roles  of  HSP60  and  HSP72,  in  the  protection  against  
interstitial  acute  pancreatitis  and the potential  therapeutic  applications  of  HSP-inducer  drugs  
in the treatment of  acute pancreatitis.  Further studies  are needed  to  investigate  the  promising  
use of these compounds in humans. 
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